Wells Fargo’s Oragenics OGEN Stock Holding History

Wells Fargo’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20	Hold	34	–	–	﹤0.01%	6937
2026 Q1	$19	Hold	34	–	–	﹤0.01%	6816
2025 Q4	$27	Hold	34	–	–	﹤0.01%	6664
2025 Q3	$45	Hold	34	–	–	﹤0.01%	6512
2025 Q2	$130	Buy	+34	New	+$172	﹤0.01%	6462
2024 Q2	–	Sell	-1	Closed	-$36	–	7302
2024 Q1	$36	Hold	1	–	–	﹤0.01%	6928
2023 Q4	$119	Hold	1	–	–	﹤0.01%	6721
2023 Q3	$59	Hold	1	–	–	﹤0.01%	6882
2023 Q2	$50	Buy	+1	New	+$93	﹤0.01%	7055
2023 Q1	–	Hold	0	–	–	–	7131
2022 Q4	–	Hold	0	–	–	–	6842
2022 Q3	–	Hold	0	–	–	–	7160
2022 Q2	–	Hold	0	–	–	–	7291
2022 Q1	–	Hold	0	–	–	–	7599
2021 Q4	–	Hold	0	–	–	–	7636
2021 Q3	–	Hold	0	–	–	–	7352
2021 Q2	–	Hold	0	–	–	–	7279
2021 Q1	–	Hold	0	–	–	–	6747
2020 Q4	–	Hold	0	–	–	–	6846
2020 Q3	–	Hold	0	–	–	–	6720
2020 Q2	–	Hold	0	–	–	–	6655
2020 Q1	–	Hold	0	–	–	–	6610
2017 Q2	–	Sell	-5	Closed	-$41K	–	6387
2017 Q1	$41K	Buy	+5	New	+$53.9K	﹤0.01%	5515
2014 Q3	–	Hold	0	–	-$1K	–	6281
2014 Q2	–	Sell	-1	Closed	-$39.5K	–	6018
2014 Q1	$48K	Buy	+1	New	+$60.7K	﹤0.01%	4943
2013 Q3	–	Hold	0	–	-$8K	–	5788
2013 Q2	–	Hold	0	–	–	–	5116

Other funds holding OGEN

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

25 LLC St. Louis, Missouri $367M AUM 10.52% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

St. Johns Investment Management Jacksonville, Florida $264M AUM 29.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

ASCM

Adkins Seale Capital Management Shreveport, Louisiana $112M AUM

Wells Fargo's OGEN Position: Q2 2026 in Review

Wells Fargo held its Oragenics (OGEN) position steady in Q2 2026 at 34 shares worth $20. The position accounts for ﹤0.01% of the portfolio, ranked #6937.

Wells Fargo first reported a position in OGEN in Q1 2014 and has held it in 11 quarters since. The position peaked at $48K in Q1 2014. 17 funds tracked by Wall St. Rank hold OGEN as of Q2 2026.

Wells Fargo held 34 shares of Oragenics worth $20 as of Q2 2026.
Wells Fargo left its Oragenics share count unchanged in Q2 2026.
Oragenics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6937 holding.
Wells Fargo first reported a position in Oragenics in Q1 2014 and has held it in 11 quarters since.
Wells Fargo's Oragenics position peaked at $48K in Q1 2014.
17 funds tracked by Wall St. Rank held Oragenics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.